Stramsen Biotech Joins Elite Class of Unicorns at $6.5 Billion Valuation and a Potential Reverse Merger Deal
/PRNewswire/ -- More than three years after establishment, Stramsen Biotech, Inc, is one of the leading plant-based biotech start-up companies in the world....